Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 7Squamous Cell Carcinoma of Head and Neck 4Carcinoma, Non-Small-Cell Lung 4Esophageal Neoplasms 3Stomach Neoplasms 2Oropharyngeal Neoplasms 2Multiple Myeloma 2Mouth Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myeloid, Acute 2Endometrial Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Tongue Neoplasms 1Retinoblastoma 1Recurrence 1Rectal Neoplasms 1Precancerous Conditions 1Pancreatic Neoplasms 1Osteoporosis 1Obesity 1Neoplasms 1Neoplasm Metastasis 1Meningioma 1Melanoma 1Lymphoma, Mantle-Cell 1

Interventions

Mirtazapine 4Megestrol Acetate 4nabiximols 1anamorelin 1Watchful Waiting 1Thalidomide 1Olanzapine 1Observation 1Megestrol 1Infliximab 1Gemcitabine 1Flurandrenolone 1EOM613 1Dronabinol 1Dexamethasone 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Anorexia × Observation × Clear all
NCT01200602 2015-11-25

Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy

Mayo Clinic

Phase 2 Terminated
1 enrolled

Anorexia, Body Weight Changes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡